1,149 results found

Copyright has been the focus of database protection but unstructured data poses challenges to traditional legal rights.

The Intellectual Property Laws Amendment (Raising the Bar) Act 2012 has been passed into law.

Given that damages will be due for Escitalopram patent infringement, it is likely that this decision will be appealed.

This article outlines main stages of the innovation process, relevant IP tools and intellectual asset advisory services.

Shiseido failed to defend its TUNING COLOR GROUP trade mark registration against removal for non-use in Australia.

In many jurisdictions it is becoming increasingly difficult to get IP protection for inventions that seem relatively simple or incremental, yet which represent significant investment for the commercialising entity. However, Australia has two regimes that may provide a strategically useful solution. The first is via the Innovation Patent system and the second via the route of Registered Designs.

A recent majority decision by the US Federal Circuit has reinforced the principle that utility and enablement (conditions of patentability) are determined as of the filing date of the patent application. A patentee cannot rely on test results that were not available at the time of filing the patent application and, accordingly, may need to delay filing until such results are available.

Patentees and patent applicants, and owners of registered IP rights should be aware that bogus invoices are on the rise.

This new legal remedy against online sites for "facilitating" copyright infringement has broad and indeterminate scope.

We are monitoring the Novel Coronavirus Pneumonia (Wuhan virus) and will provide updates as the situation evolves.

The essence of patent-system involves exchanging of technical solution disclosure for patent rights.

Substantial design registration fee reductions underpin a government policy to promote intellectual property trading.

The DGIP has also introduced virtual counters, the first virtual IP registration counters in Indonesia.

Indonesia's efforts to curb bad faith filing is a positive sign for foreign businesses wishing to register their marks.

Republic of Korea & LPDR are the newest additions to the list of countries that have appointed IPOS as an ISA/IPEA.

Discussion about recent case where plaintiff brought a TM infringement action and the defendant counterclaimed to expunge TM.

New Zealand's current Patents Act 1953 does not provide for a pharmaceutical extension of term – nor is such an extension proposed in the new Patents Bill 2008 which is presently before Parliament. However, with a US-NZ Free Trade Agreement imminent, things may be about to change.